All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia [see comments]L Degos, Pierre Fenaux, Hervé Dombret et al.|Blood|1995Cited by 373
Incidence, Clinical Features, and Outcome of AllTrans-Retinoic Acid Syndrome in 413 Cases of Newly Diagnosed Acute Promyelocytic LeukemiaStéphane de Botton, the European APL Group, L Degos et al.|Blood|1998Cited by 338
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemiaPierre Fenaux, Sylvie Chevret, A. Guerci et al.|Leukemia|2000Cited by 171
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapyStéphane de Botton, Pierre Fenaux, Miguel Á. Sanz et al.|Leukemia|2005Cited by 161
Autologous and Allogeneic Stem-Cell Transplantation As Salvage Treatment of Acute Promyelocytic Leukemia Initially Treated With All-<i>Trans</i>-Retinoic Acid: A Retrospective Analysis of the European Acute Promyelocytic Leukemia GroupStéphane de Botton, Pierre Fenaux, A Fawaz et al.|Journal of Clinical Oncology|2004Cited by 135